Vrignaud P - Search Results

1

Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.

Bissery MC, Nguyen CH, Bisagni E, Vrignaud P, Lavelle F. Bissery MC, et al. Among authors: vrignaud p. Invest New Drugs. 1993 Nov;11(4):263-77. doi: 10.1007/BF00874425. Invest New Drugs. 1993. PMID: 8157469

2

Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination.

Bissery MC, Vrignaud P, Lavelle F. Bissery MC, et al. Among authors: vrignaud p. Semin Oncol. 1995 Dec;22(6 Suppl 13):3-16. Semin Oncol. 1995. PMID: 8604451

3

Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.

Bissery MC, Vrignaud P, Lavelle F, Chabot GG. Bissery MC, et al. Among authors: vrignaud p. Anticancer Drugs. 1996 Jun;7(4):437-60. doi: 10.1097/00001813-199606000-00010. Anticancer Drugs. 1996. PMID: 8826613

4

Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors.

Vrignaud P, Sémiond D, Lejeune P, Bouchard H, Calvet L, Combeau C, Riou JF, Commerçon A, Lavelle F, Bissery MC. Vrignaud P, et al. Clin Cancer Res. 2013 Jun 1;19(11):2973-83. doi: 10.1158/1078-0432.CCR-12-3146. Epub 2013 Apr 15. Clin Cancer Res. 2013. PMID: 23589177

5

Preclinical evaluation of docetaxel (Taxotere).

Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, André S. Lavelle F, et al. Among authors: vrignaud p. Semin Oncol. 1995 Apr;22(2 Suppl 4):3-16. Semin Oncol. 1995. PMID: 7740328 Review.

6

Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.

Nguyen CH, Fan E, Riou JF, Bissery MC, Vrignaud P, Lavelle F, Bisagni E. Nguyen CH, et al. Among authors: vrignaud p. Anticancer Drug Des. 1995 Jun;10(4):277-97. Anticancer Drug Des. 1995. PMID: 7786395

7

Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing mice.

Bissery MC, Vrignaud P, Lavelle F, Chabot GG. Bissery MC, et al. Among authors: vrignaud p. Ann N Y Acad Sci. 1996 Dec 13;803:173-80. doi: 10.1111/j.1749-6632.1996.tb26386.x. Ann N Y Acad Sci. 1996. PMID: 8993510 Review. No abstract available.

8

RPR 130401, a nonpeptidomimetic farnesyltransferase inhibitor with in vivo activity.

Vrignaud P, Bissery MC, Mailliet P, Lavelle F. Vrignaud P, et al. Ann N Y Acad Sci. 1999;886:249-51. doi: 10.1111/j.1749-6632.1999.tb09428.x. Ann N Y Acad Sci. 1999. PMID: 10667231 No abstract available.

9

Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.

Sémiond D, Sidhu SS, Bissery MC, Vrignaud P. Sémiond D, et al. Among authors: vrignaud p. Cancer Chemother Pharmacol. 2013 Sep;72(3):515-28. doi: 10.1007/s00280-013-2214-x. Epub 2013 Jul 3. Cancer Chemother Pharmacol. 2013. PMID: 23820961

10

Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel).

Ojima I, Duclos O, Zucco M, Bissery MC, Combeau C, Vrignaud P, Riou JF, Lavelle F. Ojima I, et al. Among authors: vrignaud p. J Med Chem. 1994 Aug 5;37(16):2602-8. doi: 10.1021/jm00042a013. J Med Chem. 1994. PMID: 7914541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters